BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ranieri G, Marech I, Lorusso V, Goffredo V, Paradiso A, Ribatti D, Gadaleta CD. Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment. World J Gastroenterol 2014; 20(2): 486-497 [PMID: 24574717 DOI: 10.3748/wjg.v20.i2.486]
URL: https://www.wjgnet.com/1948-5182/full/v20/i2/486.htm
Number Citing Articles
1
De-Dong Cao, Hui-Lin Xu, Liang Liu, Yong-Fa Zheng, Si-Fa Gao, Xi-Ming Xu, Wei Ge. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysisOncotarget 2017; 8(27): 44976 doi: 10.18632/oncotarget.16689
2
Chunli Wu, Xiaoping Geng, Shengyun Wan, Hui Hou, Fanzong Yu, Benli Jia, Lei Wang. Cecropin-P17, an analog of Cecropin B, inhibits human hepatocellular carcinoma cell HepG-2 proliferation via regulation of ROS, Caspase, Bax, and Bcl-2Journal of Peptide Science 2015; 21(8): 661 doi: 10.1002/psc.2786
3
C. Aubé, A. Bouvier, J. Lebigot, L. Vervueren, V. Cartier, F. Oberti. Radiological treatment of HCC: Interventional radiology at the heart of managementDiagnostic and Interventional Imaging 2015; 96(6): 625 doi: 10.1016/j.diii.2015.04.008
4
C. Aubé, A. Bouvier, J. Lebigot, L. Vervueren, V. Cartier, F. Oberti. Traitement radiologique du CHC : la radiologie interventionnelle au centre de la prise en chargeJournal de Radiologie Diagnostique et Interventionnelle 2015; 96(2): 180 doi: 10.1016/j.jradio.2015.04.002
5
Katrin Fuchs, Rafael Duran, Alban Denys, Pierre E. Bize, Gerrit Borchard, Olivier Jordan. Drug-eluting embolic microspheres for local drug delivery – State of the artJournal of Controlled Release 2017; 262: 127 doi: 10.1016/j.jconrel.2017.07.016
6
Lizhi Xiao, Enhua Xiao. Blood oxygen level–dependent functional magnetic resonance imaging can evaluate the efficiency of transcatheter arterial chemoembolization in hepatocellular carcinomaJournal of Interventional Medicine 2019; 2(1): 5 doi: 10.1016/j.jimed.2019.05.002
7
Girolamo Ranieri, Michele Ammendola, Ilaria Marech, Annamaria Laterza, Ines Abbate, Caroline Oakley, Angelo Vacca, Rosario Sacco, Cosmo Damiano Gadaleta. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patientsWorld Journal of Gastroenterology 2015; 21(19): 6018-6025 doi: 10.3748/wjg.v21.i19.6018
8
Pedro Viveiros, Ahsun Riaz, Robert J. Lewandowski, Devalingam Mahalingam. Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)Cancers 2019; 11(8): 1085 doi: 10.3390/cancers11081085
9
Girolamo Ranieri, Carmelo Laface. Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated TreatmentsCancers 2020; 12(10): 2737 doi: 10.3390/cancers12102737
10
Carmelo Laface, Mariarita Laforgia, Pasquale Molinari, Ippazio Ugenti, Cosmo Damiano Gadaleta, Camillo Porta, Girolamo Ranieri. Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the ArtCancers 2021; 13(12): 3091 doi: 10.3390/cancers13123091
11
Li Wu, Jiayu Zhao, Hao Cai, Jiaqi Wang, Zhipeng Chen, Weidong Li, Xiao Liu. Dahuang Zhechong Pill Combined with Doxorubicin Induces Cell Death through Regulating Energy Metabolism in Human Hepatocellular Carcinoma CellsEvidence-Based Complementary and Alternative Medicine 2017; 2017: 1 doi: 10.1155/2017/6279576
12
Changjiang Lei, Defa Ren, Meixia Fu, Chuantao Sun, Hong Ren, Qingyun Pan, Yuan Li. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cellsOncology Letters 2019;  doi: 10.3892/ol.2019.10022
13
Wentao Jia, Lina Wang. Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor ImmunityEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/9843486